Therefore, intratracheal administration of liposomes carrying Acp5 siRNA or intraperitoneal injection of Acp5 inhibitor, AubipyOMe, significantly reversed the established pulmonary fibrosis induced by BLM. This evidence concerns the gene ACP5 and pulmonary fibrosis.